Table 1 Patient demographics, comparing CLEAR III cohort with cohort having at least 3 CSF differential cell counts available

Age (years)

59 (51–66)

59 (51–67)

57 (46–63)

58 (51–66)

Women

105 (42%)

117 (47%)

63 (45%)

71 (46%)

 White

144 (58%)

161 (64%)

74 (53%)

87 (57%)

 Black

92 (37%)

78 (31%)

59 (42%)

58 (38%)

 Native American

0

1 (<1%)

0

0

 Other

13 (5%)

11 (4%)

6 (4%)

8 (5%)

 Ethnicity: Hispanic

28 (11%)

32 (13%)

15 (11%)

17 (11%)

 Tobacco use

73 (29%)

59 (24%)

40 (29%)

41(27%)

 Cocaine

12 (5%)

18 (7%)

7 (5%)

12 (8%)

 Anticoagulation

20 (8%)

29 (12%)

15 (11%)

20 (13%)

 Hypertension

168 (67%)

202 (80%)

90 (65%)

122 (80%)

 Hyperlipidemia

240 (96%)

245 (98%)

132 (95%)

151 (99%)

 Antiplatelet use

56 (22%)

72 (29%)

28 (20%)

38 (25%)

 Mean arterial pressure

96 (86–106)

94 (86–104)

96 (88–108)

95 (87–105)

 Glasgow Coma Scale

10 (7–13)

9 (7–12)

10 (7–13)

10 (7–13)

 NIH Stroke Scale

19 (11–32)

20 (11–35)

18 (9–32)

19 (10–33)

 IVH volume (mL)

21.2 (12.7–34.2)

22.4 (12.7–39.1)

21.3 (13.7–35.3)

24.8 (16.4–39.6)

 ICH volume (mL)

8.3 (2.9–15.2)

7.2 (2.3–14.7)

8.3 (2.8–15.2)

7.7 (2.0–14.2)

 Thalamus

149 (60%)

144 (57%)

75 (54%)

83 (54%)

 Primary IVH

19 (8%)

27 (11%)

17 (12%)

16 (10%)

 Hospital arrival

1.5 (0.8–3.3)

1.5 (0.8–3.6)

1.5 (0.8–3.3)

1.6 (0.8–3.7)

 First CT

2.3 (1.3–4.6)

2.3 (1.4–5.2)

2.3 (1.3–4.7)

2.4 (1.4–5.6)

 First EVD

7.1 (4.5–11.9)

7.9 (5.1–12.0)

6.8 (4.5–10.6)

7.8 (5.1–11.0)

 Stability CT

43.1 (25.4–58.8)

44.0 (28.2–57.0)

43.6 (23.9–58.6)

43.8 (28.1–55.5)

 Randomization

51.8 (36.4–65.8)

52.2 (41.2–66.8)

52.0 (35.9–66.3)

52.0 (40.9–66.8)